Literature DB >> 7516093

Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials.

G P Browman1, L Cronin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516093

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  11 in total

Review 1.  Management of head and neck cancer in elderly patients.

Authors:  Yassine Lalami; Gilberto de Castro; Chantal Bernard-Marty; Ahmad Awada
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 2.  Emerging drugs for head and neck cancer.

Authors:  Yihui Wen; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2015-03-31       Impact factor: 4.191

Review 3.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  Successful treatment of syncope with chemotherapy irresponsive to cardiac pacemaker in head and neck cancer.

Authors:  Ji Hyun Ju; Myoung Hee Kang; Hoon Gu Kim; Gyeong Won Lee; Jung Je Park; Jin Pyeong Kim; Jung Hun Kang
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

Review 5.  Systemic therapy in head and neck cancer: changing paradigm.

Authors:  Samit Purohit; Rohan Bhise; D Lokanatha; K Govindbabu
Journal:  Indian J Surg Oncol       Date:  2012-12-01

6.  Management of unresectable head and neck cancers - a retrospective analysis at a rural medical college of India.

Authors:  Aloke Ghosh Dastidar; Somnath Saha; Abhishekh Srivastava; Debdulal Chakroborty; Balaram Sardar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

7.  Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

Authors:  Jens Wagenblast; Mehran Baghi; Christoph Arnoldner; Sotirios Bisdas; Wolfgang Gstöttner; Hanns Ackermann; Angelika May; Markus Hambek; Rainald Knecht
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-01       Impact factor: 4.553

Review 8.  Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

Authors:  C W M Reuter; M A Morgan; A Eckardt
Journal:  Br J Cancer       Date:  2007-01-16       Impact factor: 7.640

9.  Systemic therapy strategies for head-neck carcinomas: Current status.

Authors:  Thomas K Hoffmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

Review 10.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Authors:  Richard A Malthaner; Rebecca Ks Wong; R Bryan Rumble; Lisa Zuraw
Journal:  BMC Med       Date:  2004-09-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.